Anuh Pharma shares rallied 20 percent intraday Friday after getting European Medicines good manufacturing practice certificate for 2 products.
Stocks expected to gain are Sundram Fast, J&K Bank, Adani Ports, Aptech, PFC, Jubilant Life, Natco Pharma, Nitesh Estates, Globus Spirits and Emco, while stocks expected to be under pressure are Lupin, United Bank, Uco Bank, IOB, JK Tyre, Concor, Patel Integrated, Anuh Pharma, Gokaldas Exports, Kennametal, Indag Rubber, Huhtamaki PPL.
SBI | Godrej Properties | Himachal Futuristic Communication | Bharat Financial | Archies | PFC | Greenply Industries | Aptech | Grasim | Aditya Birla Nuvo | Kennametal | Prism Cement | Patel Integrated Logistics | AstraZeneca | Anuh Pharma | IOB | United Bank | UCO Bank and JK Tyre are stocks, which are in the news today.
"Following the inspection of manufacturing site of Anuh Pharma at Boisar (Maharashtra), the EDQM Ad Hoc Committee has suspended certificate of suitability for Erythromycin Ethyl Succinate, Erythromycin and Pyrazinamide," says the Mumbai-based pharma company in its filing yesterday.
Wipro | Adani Enterprises | Alphageo India | A2Z Infra | Alok Industries | Anuh Pharma | Reliance Capital | NCC | Thomas Cook | Sunflag Iron & Steel | Gulf Oil International | Cairn India | GVK Power and NTPC are stocks, which are in the news today.
Ekta Batra of CNBC-TV18 reports that this may be a big blow for the company as with regards to Erythromycin, the company has around 18 percent market share globally.
Anuh Pharma has reported a sales total income from operations of Rs 78.46 crore and a net profit of Rs 5.22 crore for the quarter ended Dec '15
Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today. We have â€“ Maruti Suzuki, Somany Ceramics, IDBI Bank, Voltas, Mangalam Drugs, Tree House, Anuh Pharma and Kwality.
"The company has received World Health Organization (WHO) prequalification for the product Sulfadoxine," says the Mumbai-based pharma company in its filing to the exchange.
SBI | ONGC | Reliance Communications | Anuh Pharma | IVRCL | Jet Airways | Golden Tobacco and Apollo Hospitals are stocks, which are in the news today.
Anuh Pharma has received good manufacturing practices (GMP) certificate from Mexican Health Authority, COFEPRIS for Cholramphenicol & Cholramphenicol Palmitate.
Anuh Pharma has reported a sales total income from operations of Rs 91.47 crore and a net profit of Rs 7.43 crore for the quarter ended Sep '15
Bipin Shah, MD, Anuh Pharma says launch of six new products will be the key growth driver in FY17. It has over Rs 60 crore cash on books and will commission a new plant on January 1, 2017.
The company at its meeting held on June 12, 2015, has considered issue of bonus equity shares in the ratio of 2:1.
Anuh Pharma has reported a sales total income from operations of Rs 70.91 crore and a net profit of Rs 4.98 crore for the quarter ended Mar '15
Anuh Pharma is looking at a revenue growth of 25 percent in FY16. Current capacity utilization stands at 65 percent and the company aims to increase it to 80 percent his fiscal year.
CNBC-TV18's Nigel D'Souza tells you six things you should know about Anuh Pharma.
Brokerage house Firstcall Research is bullish on Anuh Pharma and has recommended buy rating on the stock with a target price of Rs 550 in its research report dated March 09, 2015.
Anuh Pharma has reported a sales total income from operations of Rs 66.32 crore and a net profit of Rs 5.69 crore for the quarter ended Dec '14
Anuh Pharma has reported a sales standalone turnover of Rs 66.81 crore and a net profit of Rs 4.31 crore for the quarter ended Dec '13
Anuh Pharma has reported a sales standalone turnover of Rs 65.56 crore and a net profit of Rs 2.20 crore for the quarter ended Dec '12
Anuh Pharma has reported a sales turnover of Rs 50.84 crore and a net profit of Rs 3.30 crore for the quarter ended Jun '11